Connection

Paolo Maggi to Sofosbuvir

Back to Details
This is a "connection" page, showing publications Paolo Maggi has written about Sofosbuvir.
Paolo Maggi
Connection Strength
0.699
Sofosbuvir
  1. Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents. Eur Rev Med Pharmacol Sci. 2020 05; 24(10):5193-5194.
    View in: PubMed
    Score: 0.581
  2. Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? Clin Res Hepatol Gastroenterol. 2017 10; 41(5):e76-e79.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.